FRESC: French Real world Extensive stage SCLC Cohorts: A retrospective study on patient characteristics and treatment strategy based on KBP-2010.
Fiche publication
Date publication
décembre 2021
Journal
Lung cancer (Amsterdam, Netherlands)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier
Tous les auteurs :
Debieuvre D, Dayen C, Dixmier A, Pau D, Sibley-Revelat A, Greenwood W, Gally S, Falchero L
Lien Pubmed
Résumé
FRESC reanalyzed extensive-stage small-cell lung cancer (ES-SCLC) patient data from the French KBP-2010 cohort to describe the characteristics and therapeutic management of ES-SCLC and provide real-world estimates of survival.
Mots clés
Etoposide, Extensive Stage Small Cell Lung Carcinoma, FRESC, First line therapy, French cohorts, KBP-2010, Overall survival, Platinum, Secondary data used research
Référence
Lung Cancer. 2021 Dec 18;164:1-7